The latest closing stock price for Protagonist Therapeutics as of February 21, 2025 is 38.75.
An investor who bought $1,000 worth of Protagonist Therapeutics stock at the IPO in 2016 would have $2,312 today, roughly 2 times their original investment - a 14.23% compound annual growth rate over 9 years.
The all-time high Protagonist Therapeutics stock closing price was 49.69 on September 01, 2021.
The Protagonist Therapeutics 52-week high stock price is 48.89, which is 26.2% above the current share price.
The Protagonist Therapeutics 52-week low stock price is 24.22, which is 37.5% below the current share price.
The average Protagonist Therapeutics stock price for the last 52 weeks is 37.03.
An investor who bought $1,000 worth of Protagonist Therapeutics stock at the IPO in 2016 would have $2,312 today, roughly 2 times their original investment - a 14.23% compound annual growth rate over 9 years.
The all-time high Protagonist Therapeutics stock closing price was 49.69 on September 01, 2021.
The Protagonist Therapeutics 52-week high stock price is 48.89, which is 26.2% above the current share price.
The Protagonist Therapeutics 52-week low stock price is 24.22, which is 37.5% below the current share price.
The average Protagonist Therapeutics stock price for the last 52 weeks is 37.03.